Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease

9 Feb 2025 9:18 a.m. 9:36 a.m.
VladoPerkovic Oral Abstract Presenter AustraliaUniversity of New South Wales, Sydney, Australia